Researcher
Hans Prenen
- Keywords (University of Antwerp):Medicine
- Disciplines (University of Antwerp):Cancer biology, Cancer diagnosis, Cancer epidemiology, Cancer prevention, Cancer therapy
- Disciplines (KU Leuven):Morphological sciences, Oncology
- See also: Hans Prenen (KU Leuven)
Affiliations
- Center for Oncological Research (CORE) (Research group)
Member
From1 Oct 2020 → Today - Laboratory of Tumor Inflammation and Angiogenesis (VIB-KU Leuven) (Division)
Member
From12 Jul 2017 → 30 Apr 2018 - Clinical Digestive Oncology (Division)
Member
From1 Jan 2012 → 23 Jul 2017 - Translational Research in GastroIntestinal Disorders (Division)
Member
From1 Oct 2009 → 31 Dec 2011
Projects
1 - 2 of 2
- Development of an image-based multiparametric drug response signature to predict clinical therapy response in cancer patients from ex vivo tumoroid screenings.From1 Oct 2022 → TodayFunding: BOF - doctoral mandates
- Reinvigorating the antitumor immunity in human breastand cervical cancer with an innovative RANK(L) targeted combination strategy.From1 Nov 2021 → TodayFunding: Nonprofit institution or equivalents
Publications
11 - 20 of 150
- Comprehensive genomic profiling and therapeutic implications for patients with advanced cancers(2023)
Authors: Laure-Anne Teuwen, Evelyne Roets, Pieter D'Hoore, Patrick Pauwels, Hans Prenen
Pages: 1 - 14 - The role of immunotherapy in esophageal and gastric cancer(2023)
Authors: Hans Dedecker, Laure-Anne Teuwen, Timon Vandamme, Hans Prenen
Pages: 175 - 182 - Extensive CArdioVAscular characterization and follow-up of patients receiving immune checkpoint inhibitors(2023)
Authors: Johan De Sutter, Lieselot Croes, Delphine Vervloet, Veronique Moerman, Nico Van de Veire, Anne-Marie Willems, Marc Peeters, Hans Prenen, Christof Vulsteke
Pages: 1 - 14 - Cellular senescence in cancer(2022)
Authors: Christophe Deben, Jasper Verswyvel, Tal Flieswasser, Hans Prenen, Marc Peeters, Filip Lardon, An Wouters
Pages: 1 - 35 - Ipilimumab- and nivolumab-induced myocarditis in a patient with metastatic cholangiocarcinoma(2022)
Authors: Delphine Vervloet, Dieter Berwouts, Roel Beckers, Hans Prenen, Marc Peeters, Félix Gremonprez, Lieselot Croes, Christof Vulsteke
Pages: 1 - 7 - Systemic treatment of localized colorectal cancer(2022)
Authors: Hans Dedecker, Timon Vandamme, Laure-Anne Teuwen, Laura Wuyts, Hans Prenen, Albert Jan ten Tije, Marc Peeters
Pages: 257 - 271 - Prognostic implications of cellular senescence in resected non-small cell lung cancer(2022)
Authors: Christophe Deben, Ines De Pauw, Christophe Hermans, Hilde Lambrechts, Jasper Verswyvel, Vasiliki Siozopoulou, Patrick Pauwels, Marco Demaria, Mick van de Wiel, Jeroen Hendriks, et al.
Pages: 1526 - 1539 - eQTL set–based association analysis identifies novel susceptibility loci for Barrett esophagus and esophageal adenocarcinoma(2022)
Authors: Xiaoyu Wang, Puya Gharahkhani, David M. Levine, Rebecca C. Fitzgerald, Ines Gockel, Douglas A. Corley, Harvey A. Risch, Leslie Bernstein, Wong-Ho Chow, Lynn Onstad, et al.
Pages: 1735 - 1745 - Iron supplementation is sufficient to rescue skeletal muscle mass and function in cancer cachexia(2022)
Authors: Elisabeth Wyart, Myriam Y. Hsu, Roberta Sartori, Erica Mina, Valentina Rausch, Elisa S. Pierobon, Mariarosa Mezzanotte, Camilla Pezzini, Laure B. Bindels, Andrea Lauria, et al.
- Excellent response to MEK inhibition in an AGK-BRAF gene fusion driven carcinoma(2022)
Authors: Carl Van Paesschen, Karen Zwaenepoel, Suzan Lambin, Patrick Pauwels, Marika Rasschaert, E.V.A. Segelov, Marc Peeters, Hans Prenen
Pages: 373 - 379